4-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE, 95.0%, 1g

3,3-DIFLUOROCYCLOBUTANE-1-CARBALDEHYDE, 90%, 1g

6-(TRIFLUOROMETHYL)-1H-INDAZOLE-3-CARBOXYLIC ACID, 95%, 500mg

2,3-Dihydroxybenzoic acid, 97.0%, 500g

4,4,5,5-Tetramethyl-2-[3-(triphenylen-2-yl)phenyl]-1,3,2-dioxaborolane>98.0%(GC)(T)1g

N-(2-((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide, 98%, 50mg

2-Ethoxyphenylboronic acid, 98.0%, 10g

N-(3-bromobenzyl)-1-propanamine hydrochloride, 95.0%, 1g

(R)-6-Methoxychroman-4-amine hydrochloride, 95%, 1g

5'-O-DMT-2'-O-iBu-N-Bz-Guanosine, 100mg

2-Cyano-6-methoxybenzothiazole, 98.0%, 250mg

Trihidrato de hexacianoferrato(II) de potasio, mínimo 98,5 %, cristalizado, 1 kg, envase de plástico.

3-[3-Chloro-5-(trifluoromethyl)phenyl]propionic acid, 1g